These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7130431

  • 1. Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjects.
    Meloni T, Forteleoni G, Serra M, Daniotti S, Negri L, Giuntini P, Canepa L, Gaetani GF.
    J Clin Pharmacol; 1982; 22(8-9):418-20. PubMed ID: 7130431
    [Abstract] [Full Text] [Related]

  • 2. Effect of haemolysis on the hexose monophosphate pathway in normal and in glucose-6-phosphate dehydrogenase-deficient erythrocytes.
    Galiano S, Mareni C, Gaetani GF.
    Biochim Biophys Acta; 1978 Jan 11; 501(1):1-9. PubMed ID: 23153
    [Abstract] [Full Text] [Related]

  • 3. Haemolytic effect of two sulphonamides evaluated by a new method.
    Gaetani GD, Mareni C, Ravazzolo R, Salvidio E.
    Br J Haematol; 1976 Feb 11; 32(2):183-91. PubMed ID: 1247492
    [Abstract] [Full Text] [Related]

  • 4. Virus-induced hemolysis in erythrocytes deficient in glucose-6-phhosphate dehydrogenase.
    Necheles TF, Gorshein D.
    Science; 1968 May 03; 160(3827):535-7. PubMed ID: 5644057
    [Abstract] [Full Text] [Related]

  • 5. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.
    Ganesan S, Chaurasiya ND, Sahu R, Walker LA, Tekwani BL.
    Toxicology; 2012 Mar 29; 294(1):54-60. PubMed ID: 22330256
    [Abstract] [Full Text] [Related]

  • 6. Thrombocytopenia and haemolytic anaemia due to feprazone.
    Bell PM, Humphrey CA.
    Br Med J (Clin Res Ed); 1982 Jan 02; 284(6308):17. PubMed ID: 6797620
    [No Abstract] [Full Text] [Related]

  • 7. Salicylate-induced injury of pyruvate-kinase-deficient erythrocytes.
    Glader BE.
    N Engl J Med; 1976 Apr 22; 294(17):916-8. PubMed ID: 1256482
    [Abstract] [Full Text] [Related]

  • 8. Inducing effect of feprazone on hepatic drug-metabolizing enzymes in man.
    Morita K, Shibata H, Ono T, Shimakawa H.
    Eur J Clin Pharmacol; 1986 Apr 22; 31(1):117-8. PubMed ID: 3780819
    [Abstract] [Full Text] [Related]

  • 9. The survival of glucose-6-phosphate dehydrogenase--deficient erythrocytes in patients with typhoid fever on chloramphenicol therapy.
    Chan TK, Chesterman CN, McFadzean AJ, Todd D.
    J Lab Clin Med; 1971 Feb 22; 77(2):177-84. PubMed ID: 5540765
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of the hemolytic role of aspirin in glucose-6-phosphate dehydrogenase deficiency.
    Glader BE.
    J Pediatr; 1976 Dec 22; 89(6):1027-8. PubMed ID: 993904
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gastrointestinal blood loss on phenylbutazone and feprazone.
    Macfarlane JD, Maisey MN, Grahame R, Burry HC.
    Rheumatol Rehabil; 1976 May 22; 15(2):108-11. PubMed ID: 132693
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of pyrroline-5-carboxylic acid on nucleotide metabolism in erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient subjects.
    Yeh GC, Roth EF, Phang JM, Harris SC, Nagel RL, Rinaldi A.
    J Biol Chem; 1984 May 10; 259(9):5454-8. PubMed ID: 6201483
    [Abstract] [Full Text] [Related]

  • 17. Computer simulation of the metabolic consequences of the combined deficiency of 6-phosphogluconolactonase and glucose-6-phosphate dehydrogenase in human erythrocytes.
    Thorburn DR, Kuchel PW.
    J Lab Clin Med; 1987 Jul 10; 110(1):70-4. PubMed ID: 3598338
    [Abstract] [Full Text] [Related]

  • 18. Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs.
    Hohl RJ, Kennedy EJ, Frischer H.
    J Lab Clin Med; 1991 Apr 10; 117(4):325-31. PubMed ID: 1901343
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.